CCK receptors-related signaling involved in nitric oxide production caused by gastrin 17 in porcine coronary endothelial cells

Molecular and Cellular Endocrinology

Volumn 350, Issue 1, 2012, Pages 20-30

  Grossini, Elena ^a   Caimmi, Philippe ^a   Molinari, Claudio ^a   Uberti, Francesca ^a   Mary, David ^a   Vacca, Giovanni ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

CCK receptors; Gastrin 17; Nitric oxide; Signaling

Indexed keywords

ADENYLATE CYCLASE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GASTRIN 17; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; ENZYME ACTIVATION; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SWINE; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GASTRINS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE III; NITROSO COMPOUNDS; PENTAGASTRIN; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CHOLECYSTOKININ; SINCALIDE;

EID: 84856057913     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.11.018     Document Type: Article

References (60)

1. Baliga R.R., Burden L., Sidhu M.K., Rampling M.W., Kooner J.S. Effects of components of meals (carbohydrate, fat, protein) in causing postprandial exertional angina pectoris. Am. J. Cardiol. 1997, 79:1397-1400.
2. Berna M.J., Seiz O., Nast J.F., Benten D., Blaeker M., Koch J., Lohse A.W., Pace A. CCK1- and CCK2-receptors are expressed on pancreatic stellate cells and induce collagen production. J. Biol. Chem. 2010, 285:38905-38914.
3. Bowen J.C., Pawlik W., Fang W.F., Jacobson E.D. Pharmacologic effects of gastrointestinal hormones on intestinal oxygen consumption and blood flow. Surgery 1975, 78:515-519.
4. Cevik A.H., Ekström J. Pentagastrin-induced protein synthesis in the parotid gland of the anaesthetized rat, and its dependence on CCK-A and -B receptors and nitric oxide generation. Exp. Physiol. 2006, 91:673-679.
5. Ciccarelli M., Cipolletta E., Santulli G., Campanile A., Pumiglia K., Cervero P., Pastore L., Astone D., Trimarco B., Iaccarino G. Endothelial beta2 adrenergic signaling to AKT: role of Gi and SRC. Cell Signal 2007, 19:1949-1955.
6. Clarke P.A., Dickson J.H., Harris J.C., Grabowska A., Watson S.A. Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor. Cancer Res. 2006, 66:3504-3512.
7. Crawley J.N., Corwin R.L. Biological actions of cholecystokinin. Peptides 1994, 15:731-755.
8. Cudmore M., Ahmad S., Al-Ani B., Hewett P., Ahmed S., Ahmed A. VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways. Biochem. Biophys. Res. Commun. 2006, 345:1275-1282.
9. D'Arcangelo D., Ambrosino V., Giannuzzo M., Gaetano C., Capogrossi M.C. Axl receptor activation mediates laminar shear stress anti-apoptotic effects in human endothelial cells. Cardiovasc. Res. 2006, 71:754-763.
10. Dufresne M., Seva C., Fourmy D. Cholecystokinin and gastrin receptors. Physiol. Rev. 2006, 86:805-847.
11. Evangelista S., Maggi C.A. Protection induced by cholecystokinin-8 (CCK-8) in ethanol-induced gastric lesions is mediated via vagal capsaicin-sensitive fibres and CCKA receptors. Br. J. Pharmacol. 1991, 102:119-122.
12. Fara J.W., Madden K.S. Effect of secretin and cholecystokinin on small intestinal blood flow distribution. Am. J. Physiol. 1975, 229:1365-1370.
13. Fornai M., Colucci R., Antonioli L., Baschiera F., Ghisu N., Tuccori M., Gori G., Blandizzi C., Del Tacca M. CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon. Eur. J. Pharmacol. 2007, 557:212-220.
14. Fossa A.A., DePasquale M.J., Morrone J., Zorn S.H., Bryce D., Lowe J.A., McLean S. Cardiovascular effects of cholecystokinin-4 are mediated by the cholecystokinin-B receptor subtype in the conscious guinea pig and dog. JPET 1997, 281:180-187.
15. Gaw A.J., Hills D.M., Spraggs C.F. Characterization of the receptors and mechanisms involved in the cardiovascular actions of sCCK-8 in the pithed rat. Br. J. Pharmacol. 1995, 115:660-664.
16. 2+ concentration in parietal cells depends on adenosine 3',5'-cyclic monophosphate levels. Gastroenterology 1995, 109:1060-1067.
17. Grab D.J., Nyarko E., Nikolskaia O.V., Kim Y.V., Dumler J.S. Human brain microvascular endothelial cell traversal by Borrelia burgdorferi requires calcium signaling. Clin. Microbiol. Infect. 2009, 15:422-426.
18. Grossini E., Caimmi P.P., Molinari C., Mary D.A., Uberti F., Vacca G. Modulation of calcium movements by urocortin II in endothelial cells. Cell. Physiol. Biochem. 2010, 25:221-232.
19. Grossini E., Caimmi P., Molinari C., Uberti F., Mary D., Vacca G. Intracoronary gastrin 17 increases cardiac perfusion and function through autonomic nervous system, CCK receptors, and nitric oxide in anesthetized pigs. J. Appl. Physiol. 2011, 110:95-108.
20. Grossini E., Molinari C., Caimmi P.P., Uberti F., Vacca G. Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) channel. Br. J. Pharmacol. 2009, 156:250-261.
21. Grossini E., Molinari C., Mary D.A., Uberti F., Caimmi P.P., Surico N., Vacca G. Intracoronary genistein acutely increases coronary blood flow in anesthetized pigs through beta-adrenergic mediated nitric oxide release and estrogenic receptors. Endocrinology 2008, 149:2678-2687.
22. Hausenloy D.J., Tsang A., Mocanu M.M., Yellon D.M. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H971-H976.
23. Heinemann A., Jocic M., Holzer-Petsche U., Petho G., Peskar B.M., Horwell D.C., Holzer P. Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa. Br. J. Pharmacol. 1995, 116:2274-2278.
24. Heinemann A., Jocic M., Peskar B.M., Holzer P. CCK-evoked hyperemia in rat gastric mucosa involves neural mechanisms and nitric oxide. Am. J. Physiol. 1996, 270:G253-G258.
25. Holladay M.W., Bennett M.J., Tufano M.D., Lin C.W., Asin K.E., Witte D.G., Miller T.R., Bianchi B.R., Nikkel A.L., Bednarz L., et al. Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo. J. Med. Chem. 1992, 35:2919-2928.
26. John T.A., Ibe B.O., Raj J.U. Regulation of endothelial nitric oxide synthase: involvement of protein kinase G 1 beta, serine 116 phosphorylation and lipid structures. Clin. Exp. Pharmacol. Physiol. 2008, 35:148-158.
27. Kikuchi R., Abe Y., Iijima K., Koike T., Ara N., Uno K., Asanuma K., Asano N., Imatani A., Shimosegawa T. Low serum levels of pepsinogen and gastrin 17 are predictive of extensive gastric atrophy with high-risk of early gastric cancer. Tohoku J. Exp. Med. 2011, 223:35-44.
28. Kimura C., Oike M., Ohnaka K., Nose Y., Ito Y. Constitutive nitric oxide production in bovine aortic and brain microvascular endothelial cells: a comparative study. J. Physiol. 2004, 554:721-730.
29. Koizumi H., Yu J., Hashimoto R., Ouchi Y., Okabe T. Involvement of androgen receptor in nitric oxide production induced by icariin in human umbilical vein endothelial cells. FEBS Lett. 2010, 584:2440-2444.
30. Kombian S.B., Ananthalakshmi K.V., Parvathy S.S., Matowe W.C. Cholecystokinin-2 receptors couple to cAMP-protein kinase A to depress excitatory synaptic currents in rat nucleus accumbens in vitro. Can. J. Physiol. Pharmacol. 2006, 84:203-211.
31. Koyama T., Kimura C., Park S.J., Oike M., Ito Y. Functional implications of Ca2+ mobilizing properties for nitric oxide production in aortic endothelium. Life Sci. 2002, 72:511-520.
32. Liddle R.A. Cholecystokinin cells. Annu. Rev. Physiol. 1997, 59:221-242.
33. Lovick T.A. CCK as a modulator of cardiovascular function. J. Chem. Neuroanat. 2009, 38:176-184.
34. Maton P.N., Selden A.C., Chadwick V.S. Large and small forms of cholecystokinin in human plasma: measurement using high pressure liquid chromatography and radioimmunoassay. Regul. Pept. 1982, 4:251-260.
35. Molinari C., Grossini E., Mary D.A., Uberti F., Ghigo E., Ribichini F., Surico N., Vacca G. Prolactin induces regional vasoconstriction through the beta2-adrenergic and nitric oxide mechanisms. Endocrinology 2007, 148:4080-4090.
36. Muldowney J.A., Painter C.A., Sanders-Bush E., Brown N.J., Vaughan D.E. Acute tissue-type plasminogen activator release in human microvascular endothelial cells: the roles of Galphaq, PLC-beta, IP3 and 5,6-epoxyeicosatrienoic acid. Thromb. Haemost. 2007, 97:263-2671.
37. Noble F., Roques B.P. CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology. Prog. Neurobiol. 1999, 58:349-379.
38. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., Roques B.P. International union of pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 1999, 51:745-781.
39. Olszewska-Pazdrak B., Townsend C.M., Hellmich M.R. Agonist-independent activation of Src tyrosine kinase by a cholecystokinin-2 (CCK2) receptor splice variant. J. Biol. Chem. 2004, 279:40400-40404.
40. Parenti A., Filippi S., Amerini S., Granger H.J., Fazzini A., Ledda F. Inositol phosphate metabolism and nitric oxide synthase activity in endothelial cells are involved in the vorelaxant activity of nebivolol. J. Pharm. Exp. Ther. 2000, 292:698-703.
41. Pawlik W.W., Gustaw P., Czarnobilski K., Konturek S.J. Systemic circulatory effects of pentagastrin. Acta Physiol. Pol. 1987, 38:418-424.
42. Pique J.M., Esplugues J.V., Whittle B.J. Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion. Gastroenterology 1992, 102:168-174.
43. 2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells. J. Physiol. 2006, 576:585-594.
44. Rehfeld J.F. Accurate measurement of cholecystokinin in plasma. Clin. Chem. 1998, 44:991-1001.
45. Sartor D.M., Verberne A.J. Gastric leptin: a novel role in cardiovascular regulation. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H406-H414.
46. Schubert M.L., Peura D.A. Control of gastric acid secretion in health and disease. Gastroenterology 2008, 134:1842-1860.
47. Soll A.H. Potentiating interactions of gastric stimulants on (14C)-aminopyrine accumulation by isolated canine parietal cells. Gastroenterology 1982, 83:216-223.
48. Stroff T., Plate S., Respondek M., Müller K.M., Peskar B.M. Protection by gastrin in the rat stomach involves afferent neurons, calcitonin gene-related peptide, and nitric oxide. Gastroenterology 1995, 109:89-97.
49. Sufen G., Xianghong Y., Yongxia C., Qian P. bFGF and PDGF-BB have a synergistic effect on the proliferation, migration and VEGF release of endothelial progenitor cells. Cell Biol. Int. 2011, 35:545-551.
50. Tari A., Kamiyasu T., Yonei Y., Hamada M., Sumii M., Sumii K., Kajiyama G., Dimaline R. Role of gastrin/CCK-B receptor in the regulation of gastric acid secretion in rat. Dig. Dis. Sci. 1997, 42:1901-1907.
51. Vacca G., Mary D.A.S.G., Vono P. The effect of distension of the stomach on coronary blood flow in anaesthetized pigs. Pflugers Arch. 1994, 428:127-133.
52. Vacca G., Vono P. The primary reflex effects of distension of the stomach on heart rate, arterial pressure and left ventricular contractility in anaesthetized pig. Pflugers Arch. 1993, 425:248-255.
53. Walder C.E., Thiemermann C., Vane J.R. Endothelium-derived relaxing factor participates in the increased blood flow in response to pentagastrin in the rat stomach mucosa. Proc. Biol. Sci. 1990, 241:195-200.
54. Wiśniewska R., Wiśniewski K. The effect of cholecystokinin (CCK-33) and C-terminal fragments of cholecystokinin: CCK-8 and CCK-4 on the cardiovascular system in rats. Gen. Pharmacol. 1996, 27:159-163.
55. Wiśniewska R.J., Wiśniewski K. The effect of pentagastrin, cholecystokinin and their analogues on rat arterial blood pressure and isolated heart. Rocz. Akad. Med. Bialymst. 1996, 41:183-190.
56. Wiśniewska R.J. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A. Pol. J. Pharmacol. 1998, 50:203-212.
57. Wiśniewska R.J. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B. Pol J Pharmacol 1998, 50:213-223.
58. Wyatt A.W., Steinert J.R., Mann G.E. Modulation of the l-arginine/nitric oxide signalling pathway in vascular endothelial cells. Biochem. Soc. Symp. 2004, 71:143-156.
59. Yassin R.R. Signaling pathways mediating gastrin's growth-promoting effects. Peptides 1999, 20:885-898.
60. Zieger M., Oehrl W., Wetzker R., Henklein P., Nowak G., Kaufmann R. Different signaling pathways are involved in CCK(B) receptor-mediated MAP kinase activation in COS-7 cells. Biol. Chem. 2000, 381:763-768.